PaulEdwardO'BrienMD

PubMed

• 60 citations
  Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial.
  Day, T. A., Day, T. A., Day, T. A., Day, T. A., Day, T. A., Day, T. A., Shirai, K., Shirai, K., Shirai, K., Shirai, K., Shirai, K., Shirai, K., O'Brien, P. E., O'Brien...> ;Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Nov 14
• 36 citations
  Phase 2 trial of induction gemcitabine, oxaliplatin, and cetuximab followed by selective capecitabine-based chemoradiation in patients with borderline resectable or un...
  Nestor F. Esnaola, Uzair B. Chaudhary, Paul H. O'Brien, Elizabeth Garrett-Mayer, E. Ramsay Camp, Melanie B. Thomas, David J. Cole, Alberto J. Montero, Brenda J. Hoffma...> ;International Journal of Radiation Oncology, Biology, Physics. 2014 Mar 15
• Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: Synthesis, COX/LOX inhibition, molecular modeling, and insights into their...
  Ghatak, S.,Vyas, A.,Misra, S.,O'Brien, P.,Zambre, A.,Fresco, V. M.,Markwald, R. R.,Swamy, K. V.,Afrasiabi, Z.,Choudhury, A.,Khetmalas, M.,Padhye, S.> ;Bioorg. Med. Chem. Lett.. 2013 Dec 04
• Neuroblastoma in an adult: case presentation and literature review.
  Smith, L.,Minter, S.,O'Brien, P.,Kraveka, J. M.,Medina, A. M.,Lazarchick, J.> ;Ann. Clin. Lab. Sci.. 2013
• A randomised phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: final re...
  Ball D, Bishop J, Smith J, O'Brien P, Davis S, Ryan G, Olver I, Toner G, Walker Q, Joseph D> ;Radiother Oncol. 1999-08-01
• Junctioning of lateral and anterior fields in head and neck cancer: a dosimetric assessment of the monoisocentric technique (including reproducibility).
  Zhu L, Kron T, Barnes K, Johansen S, O'Brien P> ;Int. J. Radiat. Oncol. Biol. Phys.. 1998-04-01
• A phase III study of radiotherapy with and without continuous-infusion fluorouracil as palliation for non-small-cell lung cancer.
  Ball D, Smith J, Bishop J, Olver I, Davis S, O'Brien P, Bernshaw D, Ryan G, Millward M> ;Br. J. Cancer. 1997-01-01
• A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.
  Ball D, Bishop J, Smith J, Crennan E, O'Brien P, Davis S, Ryan G, Joseph D, Walker Q> ;Int. J. Radiat. Oncol. Biol. Phys.. 1995-01-15
• Radiation and carboplatin combined-modality therapy in non-small cell lung cancer.
  Bishop JF, Ball D, Crennan E, Ryan G, Davis S, Toner G, O'Brien P, Olver I> ;Semin. Oncol.. 1994-06-01
• Join now to see all